Indications and uses
For the temporary relief of pain and itching associated with: Sunburn, Minor Cuts & Scrapes, Minor Skin Irritation, Minor Burns
For the temporary relief of pain and itching associated with: Sunburn, Minor Cuts & Scrapes, Minor Skin Irritation, Minor Burns
Apply to affected area not more than 3 to 4 times daily. Do not use in large quantities, particularly over raw surfaces or blistered areas. Children under 2 years of age, consult a physician.
Store at Room Temperature of 15° - 30°C (59° - 86°F)
Drug Facts
| Active Ingredient | Purpose |
|---|---|
| Lidocaine HCL 4% | Topical Analgesic |
| Benzalkonium Chloride 0.13% | Topical Antiseptic |
For the temporary relief of pain and itching associated with: Sunburn, Minor Cuts & Scrapes, Minor Skin Irritation, Minor Burns
For external use only. Avoid contact with eyes.
Keep out of reach of children.
Stop use and ask doctor: if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.
If pregnant or breast-feeding, ask a health care professional before use.
Apply to affected area not more than 3 to 4 times daily. Do not use in large quantities, particularly over raw surfaces or blistered areas.
Children under 2 years of age, consult a physician.
Store at Room Temperature of 15° - 30°C (59° - 86°F)
1,3-Propanediol, Aloe Barbadensis (Aloe) Leaf Juice, Caprylyl Glycol, Chlorphenesin, Dimethyl Isosorbide, Hydroxyethyl Cellulose, Phenoxyethanol, Tocopheryl Acetate (Vitamin E), Water.
DISTRIBUTED BY
QUEST PRODUCTS LLC
Pleasant Prairie, WI 53158
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2587646 | ALOCANE plus 4 % / 0.13 % Topical Gel | PSN | 10 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | PSN | 10 |
| 2587646 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus] | SBD | 10 |
| 2375042 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel | SCD | 10 |
| 2587646 | Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel | SY | 10 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | SY | 10 |
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68229-300-02 | 2020-02-03 | C162847 | 48780-1 | 9d75b9d1-2b47-f424-e053-dadaa90a57ce | Alocane ® Plus |
| 68229-300-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2b47-f424-e053-dadaa90a57ce | Alocane ® Plus |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68229-300-01 | Alocane Plus | 3.55 mL in 1 DOSE PACK | GEL | 3.55 | 10 | |
| 68229-300-02 | Alocane Plus | 50 in 1 BOX | GEL | 50 | 10 | |
| 68229-300-03 | Alocane Plus | 1 in 1 CARTON | GEL | 1 | 10 | |
| 68229-300-03 | Alocane Plus | 59 mL in 1 TUBE | GEL | 59 | 10 | |
| 68229-300-04 | Alocane Plus | 946 mL in 1 BOTTLE, PUMP | GEL | 946 | 10 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68229-300-01 | EA - Each | 68229-300 | 379cbe87-939f-4066-8e28-789c4c3430db | 1 | 2021-01-08 |
| 68229-300-02 | EA - Each | 68229-300 | b520af95-ef09-4734-9392-dcb3d85fe981 | 1 | 2021-01-08 |
| 68229-300-03 | ML - Milliliter | 68229-300 | 27207190-a638-4f5a-b3df-27cde1c29d3b | 1 | 2021-09-07 |
| 68229-300-04 | ML - Milliliter | 68229-300 | 74748392-6b14-42fc-8c52-9340ed8a8bb3 | 1 | 2021-09-07 |
| 68229-300-05 | ML - Milliliter | 68229-300 | e75b92b2-0797-472a-8c2e-1f676e76b8ff | 2 | 2022-02-07 |
| 68229-300-06 | ML - Milliliter | 68229-300 | 110ad54a-6f0b-4007-9433-4a41ec8d3543 | 2 | 2022-02-07 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzalkonium Chloride | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| Lidocaine Hydrochloride | ACTIVE INGREDIENT | V13007Z41A | 1 | |
| Benzalkonium | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| Lidocaine | ACTIVE MOIETY | 98PI200987 | 1 | |
| .Alpha.-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Chlorphenesin | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| Dimethyl Isosorbide | INACTIVE INGREDIENT | SA6A6V432S | 1 | |
| Hydroxyethyl Cellulose (5500 MPA.S AT 2%) | INACTIVE INGREDIENT | M825OX60H9 | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Propanediol | INACTIVE INGREDIENT | 5965N8W85T | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68229-300 | 68229-300-01, 68229-300-02, 68229-300-03, 68229-300-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PROPANEDIOL | 5965N8W85T | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| DIMETHYL ISOSORBIDE | SA6A6V432S | IACT |
| HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%) | M825OX60H9 | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| CHLORPHENESIN | I670DAL4SZ | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| WATER | 059QF0KO0R | IACT |
| LIDOCAINE HYDROCHLORIDE | V13007Z41A | ACTIR |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | CREAM / TOPICAL | 15 %w/w | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | AEROSOL, FOAM / TOPICAL | 5.44 %w/w | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | CREAM / TOPICAL | 15 %w/w | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | CREAM / TOPICAL | 15 %w/w | ||
| Hydroxyethyl Cellulose (5500 MPA.S AT 2%) | HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%) | M825OX60H9 | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | CREAM / TOPICAL | 15 %w/w | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | AEROSOL, FOAM / TOPICAL | 5.44 %w/w | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| Hydroxyethyl Cellulose (5500 MPA.S AT 2%) | HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%) | M825OX60H9 | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | CREAM / TOPICAL | 15 %w/w | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| Hydroxyethyl Cellulose (5500 MPA.S AT 2%) | HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%) | M825OX60H9 | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| Hydroxyethyl Cellulose (5500 MPA.S AT 2%) | HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%) | M825OX60H9 | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | AEROSOL, FOAM / TOPICAL | 5.44 %w/w | ||
| Hydroxyethyl Cellulose (5500 MPA.S AT 2%) | HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%) | M825OX60H9 | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | AEROSOL, FOAM / TOPICAL | 5.44 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | AEROSOL, FOAM / TOPICAL | 5.44 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alocane Plus | LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE | Quest Products LLC | b3ec09b9-7511-0895-e053-2a95a90a7840 | 2025-12-04 | Warnings | 68229-300 |
| Alocane Plus | LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE | Quest Products, Inc. | 24538037-1d74-48a0-b909-98ecc57651fe | 2025-07-17 | Warnings | 68229-300-01 68229-300-03 68229-300-02 68229-300-04 68229-300 68229030002 68229030001 68229030004 68229030003 3a24dd33-2000-ccc2-e063-6394a90a8f13 24538037-1d74-48a0-b909-98ecc57651fe |
Adverse event summaries are temporarily unavailable. Other product information remains available.